Logo
Hyaron Skin booster 1×2.5mL Syringes

Hyaron Skin booster 1×2.5mL Syringes

Hyaron

Injectable skin booster
  • CE Marked hyaluronic acid injectable skin booster/medical device as indicated by multiple European and UK distributors.
  • Manufactured by Dongkook Pharmaceutical Co., Ltd., a regulated pharmaceutical manufacturer in South Korea operating under GMP Compliant standards.
  • Supplied in the UK by AestheticsRX Pharma Ltd, a GPhC Registered pharmacy (Reg. No. 9012430).
Hyaluronic acid skin booster

Description

Hyaron Skin Booster 1×2.5mL is an injectable sodium hyaluronate (hyaluronic acid) skin booster presented in a single prefilled 2.5 mL syringe. It is designed to deeply hydrate and revitalise the skin from within, restoring moisture, improving elasticity, and giving the skin a smoother, plumper, and more radiant appearance. By delivering hyaluronic acid directly beneath the skin surface, it helps reduce fine lines, dullness, and visible dehydration, making it suitable for a wide range of skin types when administered by trained professionals.

Bnefits

  • Provides deep, long-lasting hydration by delivering hyaluronic acid directly into the skin.
  • Improves skin elasticity and firmness through enhanced moisture retention.
  • Helps smooth the appearance of fine lines and superficial wrinkles.
  • Revitalises dull, tired, or dehydrated skin for a fresher, more radiant complexion.
  • Supports overall skin texture improvement, leaving skin feeling softer and plumper.
  • Suitable for a wide range of skin types when used by trained medical or aesthetic practitioners.
  • Injectable format allows targeted treatment of problem areas rather than generalised topical application.

Indications

  • Dehydrated or dull facial skin
  • Fine lines and superficial wrinkles
  • Loss of elasticity and early signs of skin ageing
  • Uneven or rough skin texture
  • Skin requiring biorevitalisation and intensive hydration
  • Patients seeking a refreshed, natural glow without heavy volumising fillers

Composition

  • Sodium Hyaluronate 25 mg/mL (non-stabilised hyaluronic acid)
  • Sodium Chloride 17.0 mg
  • Monobasic sodium phosphate approximately 1.2 mg
  • Water for injection up to 2.0 mL per syringe

Formulation

  • Non-crosslinked sodium hyaluronate solution for intradermal / superficial subcutaneous injection.
  • Each 2.5 mL prefilled syringe contains 25 mg of sodium hyaluronate (approximately 10 mg/mL).
  • Clear, smooth, gel-like injectable solution designed for mesotherapy-style skin booster treatments.

Packaging

  • Unit presentation: 1 × 2.5 mL prefilled syringe of Hyaron Skin Booster.
  • The core product line is also commonly supplied in boxes of 10 × 2.5 mL prefilled syringes; this SKU represents a single-syringe option.
  • Sterile, single-use syringe intended for professional use only.

Usage

  • For professional use only; must be administered by appropriately trained, qualified, and insured healthcare or aesthetic practitioners.
  • Injected intradermally or in very superficial subcutaneous tissue using microinjection / mesotherapy techniques, following local clinical protocols.
  • Commonly used in a series of sessions spaced approximately 1–2 weeks apart, with maintenance treatments as advised by the practitioner.
  • Do not inject into blood vessels, areas with active infection, or directly into inflammatory skin lesions.
  • Use appropriate aseptic technique, including skin disinfection and use of sterile, single-use needles and syringes.
  • Dispose of used materials in approved sharps and clinical waste containers according to local regulations.
  • Patients should follow practitioner aftercare advice, which may include avoiding makeup, saunas, sunbeds, or strenuous exercise immediately after treatment.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid (sodium hyaluronate) or any listed excipients.
  • Active skin infections or inflammatory conditions at or near the intended injection site (e.g. herpes simplex, bacterial or fungal infection).
  • Severe inflammatory dermatoses in the treatment area (e.g. active dermatitis or severe acne flares).
  • History of severe allergic reactions or anaphylaxis to injectable products.
  • Bleeding disorders or current use of anticoagulant therapy that significantly increases bleeding risk, as assessed by the treating clinician.
  • Pregnancy and breastfeeding (generally avoided due to limited safety data).
  • Autoimmune disease or significant immunosuppression may be relative contraindications and require clinician assessment.
  • Do not inject intravascularly or in areas with compromised vascular supply.

Adverse Effects

  • Transient erythema (redness), swelling, or tenderness at injection sites.
  • Mild to moderate pain or discomfort during and shortly after injection.
  • Bruising or small hematomas around treated areas.
  • Temporary edema or small palpable lumps due to localised product placement.
  • Mild itching or irritation as the product settles.
  • Rarely, infection at the injection site if aseptic technique is not strictly followed.
  • Rare hypersensitivity reactions or delayed inflammatory responses.
  • Very rare but serious complications such as vascular occlusion, ischemia, or tissue necrosis if inadvertently injected into or compressing a blood vessel.

Storage Conditions

  • Store in original packaging to protect from light and contamination.
  • Keep within the temperature range specified on the packaging (commonly 2–25 °C, not frozen); follow the exact storage guidance provided with the product.
  • Do not freeze; freezing can damage the hyaluronic acid gel structure.
  • Protect from excessive heat and direct sunlight.
  • Do not use if packaging is damaged, if the syringe is compromised, or if the solution appears discoloured or contains particulate matter.
  • Keep out of the sight and reach of children.

Duration

Typically administered as a course of multiple treatment sessions over several weeks, with results often maintained for several months; exact duration and protocol depend on individual skin condition and practitioner preference.

Onset

Hydration and plumping effects may be noticeable shortly after treatment or within a few days, with further improvements in texture and radiance developing over the following weeks.

Browse more Injectable skin booster

Top Treatments

Top Cities in the UK